BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19837296)

  • 1. Foot and mouth disease virus vaccines.
    Rodriguez LL; Grubman MJ
    Vaccine; 2009 Nov; 27 Suppl 4():D90-4. PubMed ID: 19837296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of epitope-tagged foot-and-mouth disease virus.
    Seago J; Jackson T; Doel C; Fry E; Stuart D; Harmsen MM; Charleston B; Juleff N
    J Gen Virol; 2012 Nov; 93(Pt 11):2371-2381. PubMed ID: 22815275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of cell type and cell culture media on the propagation of foot-and-mouth disease virus with regard to vaccine quality.
    Dill V; Hoffmann B; Zimmer A; Beer M; Eschbaumer M
    Virol J; 2018 Mar; 15(1):46. PubMed ID: 29548334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study the Profile of Foot-and-mouth Disease Virus Protein by Electrophoresis and Identification of the Immunodominant Proteins.
    Fariba G; Rasool M; Mahsa H
    Arch Razi Inst; 2023 Oct; 78(5):1563-1571. PubMed ID: 38590683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why Foot-and-Mouth Disease-Free with Vaccination Should Be Equivalent to Foot-and-Mouth Disease-Free without Vaccination.
    Moura P; Kihm U; Schudel A; Bergmann I; Buholzer P
    Vet Sci; 2024 Jun; 11(6):. PubMed ID: 38922028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of vaccines toward the global control and eradication of foot-and-mouth disease.
    Rodriguez LL; Gay CG
    Expert Rev Vaccines; 2011 Mar; 10(3):377-87. PubMed ID: 21434805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches to foot-and-mouth disease vaccine development.
    Ludi A; Rodriguez L
    Dev Biol (Basel); 2013; 135():107-16. PubMed ID: 23689888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced protection against FMDV in cattle after prime- boost vaccination based on mucosal and inactivated FMD vaccine.
    Khalifa ME; El-Deeb AH; Zeidan SM; Hussein HA; Abu-El-Naga HI
    Vet Microbiol; 2017 Oct; 210():1-7. PubMed ID: 29103677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Foot-and-mouth disease: past, present and future.
    Jamal SM; Belsham GJ
    Vet Res; 2013 Dec; 44(1):116. PubMed ID: 24308718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The economic impacts of foot and mouth disease - what are they, how big are they and where do they occur?
    Knight-Jones TJ; Rushton J
    Prev Vet Med; 2013 Nov; 112(3-4):161-73. PubMed ID: 23958457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Foot-and-mouth disease vaccines: progress and problems.
    Cao Y; Lu Z; Liu Z
    Expert Rev Vaccines; 2016 Jun; 15(6):783-9. PubMed ID: 26760264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Foot-and-mouth disease vaccines: recent updates and future perspectives.
    Kamel M; El-Sayed A; CastaƱeda Vazquez H
    Arch Virol; 2019 Jun; 164(6):1501-1513. PubMed ID: 30888563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between 146S Antigen Content in Foot-and-Mouth Disease Inactivated Vaccines and Immunogenicity Level and Vaccine Potency Alternative Test Methods.
    Li Y; Yang R; Yin F; Zhang H; Zhai G; Sun S; Tian B; Zeng Q
    Vet Sci; 2024 Apr; 11(4):. PubMed ID: 38668435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antigen-specific CD8 T cells contribute to early protection against FMDV through swine DC vaccination.
    Mu S; Chen L; Dong H; Li S; Zhang Y; Yin S; Tian Y; Ding Y; Sun S; Shang S; Guo H
    J Virol; 2024 Feb; 98(2):e0200223. PubMed ID: 38289108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of virus-like particles (VLPs) of foot-and-mouth disease virus (FMDV) using Saccharomyces cerevisiae.
    Le NMT; So KK; Chun J; Kim DH
    Appl Microbiol Biotechnol; 2024 Dec; 108(1):81. PubMed ID: 38194136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivated vaccine with glycyrrhizic acid adjuvant elicits potent innate and adaptive immune responses against foot-and-mouth disease.
    Shin S; Kim HW; Ko MK; Park SH; Kim SM; Park JH; Lee MJ
    Front Microbiol; 2023; 14():1289065. PubMed ID: 38029108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the effectiveness of foot-and-mouth disease vaccination of animals in the buffer zone of the Republic of Armenia in 2016-2020.
    Kharatyan S; Sargsyan K; Elbakyan H; Markosyan T; Tumanyan P; Hakobyan V; Sargsyan V; Badalyan M; Chobanyan G; Achenbach JE
    BMC Vet Res; 2023 Sep; 19(1):176. PubMed ID: 37773157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Effect of Foot-and-Mouth Disease Virus Vaccine Structural Protein Antibody Positivity Rates in Piglets Orally Treated with Amino-Zinc Complex.
    Lee BR; Lee HJ; Kim NH; Kim YS; Park KI
    Animals (Basel); 2023 Jun; 13(12):. PubMed ID: 37370536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Adjuvant Formulations Enhanced an Immune Response of Trivalent Foot and Mouth Disease Vaccine in Cattle.
    Ayele G; Getachew B; Bari FD; Bayissa B; Muluneh A; Abayneh T; Gelaye E; Edao BM
    Vet Med (Auckl); 2023; 14():47-62. PubMed ID: 37090231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of oestrus synchronisation through ovulation delay by vaccination against foot-and-mouth disease in Hanwoo (Bos taurus coreanae) cows.
    Kim D; Kwon WS; Ha J; Kim J; Kim D; Lee W; Moon J; Yi J
    Vet Med Sci; 2023 Mar; 9(2):974-981. PubMed ID: 36634247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.